Well not really, because in addition to running BNPL they are also spending an unspecified amount of money on development work for their other business goals, ie growing their transaction processing model.
When they were running iSentric they just had iSentric and not enough money to do any kind of development. It's not a reasonable comparison.
Example
>After BNPL, at 31/21/21, they had one hundred and thirty-three (133) staff. Staff expenses are now ~$1M per quarter.
How many of those staff are required to run and maintain BNPL, and how many of those are development staff?
It's not really "after BNPL", it's "after cap raise", which lead to multiple areas of development.
Neither of us know, can't really make any kind of reasonable estimates about any of it.
It seems pretty obvious to me though that given the amount of stuff in their statements are not direct BNPL related projects that a significant percentage of their expenditure is development, not basic operations.
Edit: Very interesting that they have 19 times more staff for only 2.7 times more money I never noticed that before.
- Forums
- ASX - By Stock
- OVT
- Ann: December Quarterly Activities Report
Ann: December Quarterly Activities Report, page-109
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $54.81M |
Open | High | Low | Value | Volume |
2.9¢ | 3.0¢ | 2.7¢ | $2.134M | 74.89M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 2965212 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 3311896 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1954138 | 0.027 |
22 | 5939671 | 0.026 |
19 | 4456646 | 0.025 |
15 | 2678727 | 0.024 |
11 | 3629075 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 3311896 | 3 |
0.029 | 1754081 | 5 |
0.030 | 1602000 | 5 |
0.031 | 1486933 | 6 |
0.032 | 2325420 | 10 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
OVT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online